The orphan G-protein coupled receptor RDC1: evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover

Osteoarthritis and Cartilage
S W JonesM R C Needham

Abstract

RDC1 is a class A orphan G-protein coupled receptor of unknown function. The purpose of this study was to identify compound RDC1 agonists and use these as tools to determine the effect of RDC1 activation in human chondrocytes and cartilage explant tissue. Computational chemistry was employed to build a homology model of the RDC1 receptor. A virtual screen of in-house compounds was then performed and positive hits screened for their ability to invoke a Ca2+ response in a recombinant RDC1 HEK293 cell line, as measured by FLIPR. The effect of RDC1 activation on human chondrocytes and cartilage explant gene expression was determined by quantitative real-time polymerase chain reaction (PCR), and these effects validated as being mediated by RDC1 using siRNA antisense. Tissue expression profiling demonstrated that RDC1 expression was predominant in cartilage tissue. Treatment of human primary chondrocytes with RDC1 agonist induced a Ca2+ response, suggesting the receptor is active in this tissue type. Treatment for 24h with RDC1 agonist led to altered expression of a number of genes associated with chondrocyte hypertrophy and increased matrix degradation in human primary chondrocytes, and elevated total matrix metalloproteinase (MMP) ...Continue Reading

References

Dec 26, 1995·Biochemical and Biophysical Research Communications·S Kapas, A J Clark
Jan 19, 1996·The Journal of Biological Chemistry·V KnäuperG Murphy
Mar 24, 1999·Arthritis and Rheumatism·L S LohmanderA R Poole
Apr 3, 2001·Trends in Cardiovascular Medicine·H P Gerber, N Ferrara
Mar 1, 2002·Osteoarthritis and Cartilage·S HashimotoM Lotz
Mar 11, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Xin Qing, Ingegerd M Keith
Apr 12, 2003·Osteoarthritis and Cartilage·T NakaseH Yoshikawa
Aug 2, 2003·The Journal of Biological Chemistry·Michael A PrattaElizabeth C Arner
Sep 25, 2003·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·H OkadaH Kanzaki
Jul 28, 2004·The American Journal of Pathology·Stephen L MaddenKevin A Walter
Aug 31, 2004·Arthritis and Rheumatism·Hyunchul JoMyung Chul Lee
Aug 19, 2005·The Journal of Biological Chemistry·Karl BalabanianFrançoise Bachelerie

❮ Previous
Next ❯

Citations

Dec 14, 2006·Cancer Metastasis Reviews·Jianhua WangRussell S Taichman
Sep 15, 2010·Cancer Metastasis Reviews·Xueqing SunJianhua Wang
Oct 29, 2008·Journal of Clinical Immunology·Vishwas TripathiKalpana Luthra
Jan 22, 2008·Arthritis Research & Therapy·Kristin AndreasMichael Sittinger
Jul 2, 2014·Journal of Molecular Endocrinology·Andrei S Chagin, Henry M Kronenberg
Jun 21, 2014·Expert Opinion on Therapeutic Targets·Amanda VillalvillaGabriel Herrero-Beaumont
Nov 17, 2012·Trends in Molecular Medicine·Lorena Sánchez-MartínCarlos Cabañas
Mar 20, 2012·European Journal of Medicinal Chemistry·Maikel WijtmansRob Leurs
Dec 14, 2011·Advanced Drug Delivery Reviews·Tim WernerW Bret Church
Oct 20, 2009·European Journal of Pharmacology·Radoslaw B MaksymMariusz Z Ratajczak
Apr 3, 2009·Molecular and Cellular Neurosciences·Nicolas CubedoMireille Rossel
Apr 30, 2008·Genesis : the Journal of Genetics and Development·Han GerritsJan A Gossen
Jun 28, 2011·British Journal of Pharmacology·D J ScholtenR Leurs
Sep 13, 2014·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Florentine C Moazedi-FuerstWinfried B Graninger
Sep 6, 2008·Current Opinion in Pharmacology·Edward R LavallieMichael E Burczynski
Oct 13, 2017·International Journal of Clinical Oncology·Alireza NazariGholamhossein Hassanshahi
Apr 14, 2018·PloS One·Jonathan BakerAndrew D Rowan
Feb 13, 2019·BMC Musculoskeletal Disorders·Mhairi A MacfadyenSimon W Jones
Oct 2, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ivy A W HoPaula Y P Lam
Apr 24, 2017·Cellular and Molecular Life Sciences : CMLS·Andrea LolliRoberta Piva
Dec 1, 2020·Osteoarthritis and Cartilage·Jiazhou LiXuedong Zhou
Aug 28, 2021·Biomedicines·Susanne N WijesingheSimon W Jones

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.